Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2002 1
2004 1
2005 3
2007 3
2008 3
2009 6
2010 2
2011 3
2012 5
2013 2
2015 2
2016 4
2017 3
2018 5
2019 8
2020 8
2021 2
2022 6
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Results by year

Filters applied: . Clear all
Page 1
COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals.
Faksova K, Walsh D, Jiang Y, Griffin J, Phillips A, Gentile A, Kwong JC, Macartney K, Naus M, Grange Z, Escolano S, Sepulveda G, Shetty A, Pillsbury A, Sullivan C, Naveed Z, Janjua NZ, Giglio N, Perälä J, Nasreen S, Gidding H, Hovi P, Vo T, Cui F, Deng L, Cullen L, Artama M, Lu H, Clothier HJ, Batty K, Paynter J, Petousis-Harris H, Buttery J, Black S, Hviid A. Faksova K, et al. Among authors: petousis harris h. Vaccine. 2024 Apr 2;42(9):2200-2211. doi: 10.1016/j.vaccine.2024.01.100. Epub 2024 Feb 12. Vaccine. 2024. PMID: 38350768 Free article.
Background rates of adverse events of special interest for COVID-19 vaccines: A multinational Global Vaccine Data Network (GVDN) analysis.
Phillips A, Jiang Y, Walsh D, Andrews N, Artama M, Clothier H, Cullen L, Deng L, Escolano S, Gentile A, Gidding G, Giglio N, Junker T, Huang W, Janjua N, Kwong J, Li J, Nasreen S, Naus M, Naveed Z, Pillsbury A, Stowe J, Vo T, Buttery J, Petousis-Harris H, Black S, Hviid A. Phillips A, et al. Among authors: petousis harris h. Vaccine. 2023 Oct 6;41(42):6227-6238. doi: 10.1016/j.vaccine.2023.08.079. Epub 2023 Sep 5. Vaccine. 2023. PMID: 37673715 Free article.
Assessing the Safety of COVID-19 Vaccines: A Primer.
Petousis-Harris H. Petousis-Harris H. Drug Saf. 2020 Dec;43(12):1205-1210. doi: 10.1007/s40264-020-01002-6. Epub 2020 Sep 30. Drug Saf. 2020. PMID: 32997318 Free PMC article.
Author reply to VA-MENGOC-BC cross-protection (2018HV0022).
Petousis-Harris H. Petousis-Harris H. Hum Vaccin Immunother. 2018 May 4;14(5):1069. doi: 10.1080/21645515.2018.1448335. Epub 2018 Apr 30. Hum Vaccin Immunother. 2018. PMID: 29659326 Free PMC article. No abstract available.
Proposed HPV vaccination syndrome is unsubstantiated.
Petousis-Harris H. Petousis-Harris H. Clin Rheumatol. 2016 Mar;35(3):833-4. doi: 10.1007/s10067-015-3090-z. Epub 2015 Oct 21. Clin Rheumatol. 2016. PMID: 26490038 No abstract available.
Methodological frontiers in vaccine safety: qualifying available evidence for rare events, use of distributed data networks to monitor vaccine safety issues, and monitoring the safety of pregnancy interventions.
Dodd C, Andrews N, Petousis-Harris H, Sturkenboom M, Omer SB, Black S. Dodd C, et al. Among authors: petousis harris h. BMJ Glob Health. 2021 May;6(Suppl 2):e003540. doi: 10.1136/bmjgh-2020-003540. BMJ Glob Health. 2021. PMID: 34011501 Free PMC article. Review.
68 results